1. Home
  2. CDNA vs CRTO Comparison

CDNA vs CRTO Comparison

Compare CDNA & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$22.23

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Criteo S.A.

CRTO

Criteo S.A.

N/A

Current Price

$17.14

Market Cap

940.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNA
CRTO
Founded
1998
2005
Country
United States
France
Employees
N/A
N/A
Industry
Medical Specialities
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
940.1M
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
CDNA
CRTO
Price
$22.23
$17.14
Analyst Decision
Buy
Strong Buy
Analyst Count
6
10
Target Price
$28.00
$34.00
AVG Volume (30 Days)
582.4K
372.8K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.95
EPS
0.05
0.15
Revenue
$48,324,000.00
$2,296,692,000.00
Revenue This Year
$16.01
N/A
Revenue Next Year
$11.31
$5.54
P/E Ratio
$446.20
$114.33
Revenue Growth
18.93
27.65
52 Week Low
$10.96
$15.58
52 Week High
$23.24
$26.98

Technical Indicators

Market Signals
Indicator
CDNA
CRTO
Relative Strength Index (RSI) 62.79 46.32
Support Level $15.80 $16.98
Resistance Level $22.89 $19.98
Average True Range (ATR) 0.92 0.69
MACD 0.05 0.11
Stochastic Oscillator 89.08 41.51

Price Performance

Historical Comparison
CDNA
CRTO

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

Share on Social Networks: